BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18475186)

  • 21. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.
    Tzakis AG; Kato T; Nishida S; Levi DM; Madariaga JR; Nery JR; Mittal N; Regev A; Cantwell P; Gyamfi A; Weppler D; Miller J; Tryphonopoulos P; Ruiz P
    Transplantation; 2003 Apr; 75(8):1227-31. PubMed ID: 12717207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients.
    Newland DM; Royston MJ; McDonald DR; Nemeth TL; Wallace-Boughter K; Carlin K; Horslen S
    Pediatr Transplant; 2019 Dec; 23(8):e13573. PubMed ID: 31512802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome.
    Ramos E; Hernández F; Andres A; Martínez-Ojinaga E; Molina M; Sarría J; Lopez-Santamaria M; Prieto G
    Pediatr Transplant; 2013 Aug; 17(5):472-8. PubMed ID: 23730927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR; Alnimri M; Weber-Shrikant E; Kohli R; Said M; Patel S; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):458-61. PubMed ID: 21440733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
    Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital.
    Chang HK; Kim SY; Kim JI; Kim SI; Whang JK; Choi JY; Park JM; Jung ES; Rha SE; Kim DG; Moon IS; Lee MD
    Transplant Proc; 2016 Mar; 48(2):473-8. PubMed ID: 27109981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J; Terasaki PI
    Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of rejection episodes in over 100 pediatric intestinal transplant recipients.
    Selvaggi G; Kato T; Gaynor JJ; Thompson J; Nishida S; Madariaga J; Levi D; Moon J; Ruiz P; Cantwell P; Tuteja S; Tzakis A
    Transplant Proc; 2006; 38(6):1711-2. PubMed ID: 16908257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
    Quintini C; Kato T; Gaynor JJ; Ueno T; Selvaggi G; Gordon P; McLaughlin G; Tompson J; Ruiz P; Tzakis A
    Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction.
    Kubal CA; Mangus RS; Saxena R; Lobashevsky A; Higgins N; Agarwal A; Fridell JA; Tector AJ
    Transplantation; 2014 Jan; 97(1):56-63. PubMed ID: 24030603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD; Loss GE; Blazek J; Nair S; Mason AL
    Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term efficacy of multivisceral transplantation.
    Madariaga JR; Reyes J; Mazariegos G; Fung JJ; Starzl TE; Abu-Elmagd K
    Transplant Proc; 2000 Sep; 32(6):1219-20. PubMed ID: 10995918
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
    Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Martin L; Koritsky DA; Cunha-Melo JR; Sogawa H; Irish W; Tzakis A; Mazariegos G
    Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in intestinal and multivisceral transplantation.
    Mangus RS; Tector AJ; Fridell JA; Kazimi M; Hollinger E; Vianna RM
    Transplantation; 2008 Jul; 86(2):298-302. PubMed ID: 18645494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.